Treatment of cancer patients with infusions of plasmin.
D005260:Female; D005341:Fibrinolysin / Q000008:administration & dosage*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*
D006493:Heparin; D005341:Fibrinolysin